{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:17:15Z","timestamp":1761542235783,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.cgh.2013.09.065","type":"journal-article","created":{"date-parts":[[2013,10,10]],"date-time":"2013-10-10T00:06:45Z","timestamp":1381363605000},"page":"341-345","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Risk of Pure Red Cell Aplasia in Patients With Hepatitis C Receiving Antiviral Therapy and an Erythropoiesis-Stimulating Agent"],"prefix":"10.1016","volume":"12","author":[{"given":"Jerome","family":"Rossert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Smirnakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel T.","family":"Mytych","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elias","family":"Kouchakji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Casadevall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2013.09.065_bib1","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1600-0609.2004.00348.x","article-title":"Recommendations on haematological criteria for the diagnosis of epoetin-induced pure red cell aplasia","volume":"73","author":"Casadevall","year":"2004","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.cgh.2013.09.065_bib2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2215\/CJN.02440607","article-title":"Pure red cell aplasia induced by erythropoiesis-stimulating agents","volume":"3","author":"Pollock","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.cgh.2013.09.065_bib3","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1056\/NEJMct061675","article-title":"Peginterferon and ribavirin for chronic hepatitis C","volume":"355","author":"Hoofnagle","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2013.09.065_bib4","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/hep.24641","article-title":"An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases","volume":"54","author":"Ghany","year":"2011","journal-title":"Hepatology"},{"issue":"9 Suppl 6","key":"10.1016\/j.cgh.2013.09.065_bib5","article-title":"Anemia management in the era of triple combination therapy for chronic HCV","volume":"8","author":"Jacobson","year":"2012","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"10.1016\/j.cgh.2013.09.065_bib6","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/hep.26096","article-title":"Anemia during treatment with peginterferon Alfa-2b\/ribavirin and boceprevir: analysis from the serine protease inhibitor therapy 2 (SPRINT-2) trial","volume":"57","author":"Sulkowski","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2013.09.065_bib7","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1053\/j.gastro.2004.01.027","article-title":"Epoetin alfa maintains ribavirin dose in HCV-infected patients: a prospective, double-blind, randomized controlled study","volume":"126","author":"Afdhal","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2013.09.065_bib8","doi-asserted-by":"crossref","first-page":"S549","DOI":"10.1016\/S0168-8278(12)61410-X","article-title":"A\u00a0randomized trial comparing ribavirin dose reduction versus erythropoietin for anemia management in previously untreated patients with chronic hepatitus C receiving boceprevir plus peginterferon\/ribavirin","volume":"56","author":"Poordad","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2013.09.065_bib9","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/ndt\/gfr213","article-title":"Detection of anti-ESA antibodies in human samples from PRCA and non-PRCA patients: an immunoassay platform comparison","volume":"27","author":"Barger","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cgh.2013.09.065_bib10","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/S0140-6736(04)16302-2","article-title":"Treatment of erythropoietin-induced pure red cell aplasia: a retrospective study","volume":"363","author":"Verhelst","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2013.09.065_bib11","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1056\/NEJMoa011931","article-title":"Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin","volume":"346","author":"Casadevall","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2013.09.065_bib12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ajh.2830270119","article-title":"Letter to the editor: the possible involvement of interferons in acquired pure red cell aplasia","volume":"27","author":"Schattner","year":"1988","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cgh.2013.09.065_bib13","first-page":"113","article-title":"Pure red cell aplasia associated with hepatitis C infection","volume":"314","author":"al-Awami","year":"1997","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.cgh.2013.09.065_bib14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000040908","article-title":"Pure red cell aplasia responsive to interferon-alpha in a patient with hepatitis C virus infection","volume":"100","author":"Davidovitz","year":"1998","journal-title":"Acta Haematol"},{"key":"10.1016\/j.cgh.2013.09.065_bib15","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.amjmed.2004.04.023","article-title":"Pure red cell aplasia following pegylated interferon alpha treatment","volume":"117","author":"Arcasoy","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.cgh.2013.09.065_bib16","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/ajh.21229","article-title":"Pure red-cell aplasia associated with pegylated interferon-alpha-2b plus ribavirin","volume":"83","author":"Miura","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cgh.2013.09.065_bib17","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJM200403183501222","article-title":"Ribavirin-induced pure red-cell aplasia during treatment of chronic hepatitis C","volume":"350","author":"Tanaka","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2013.09.065_bib18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1365-2257.2000.00278.x","article-title":"Pure red cell aplasia in a patient with chronic granulocytic leukaemia treated with interferon-alpha","volume":"22","author":"Hirri","year":"2000","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.cgh.2013.09.065_bib19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00001813-200101000-00002","article-title":"Interferon-alpha-induced pure red cell aplasia following chronic myelogenous leukemia","volume":"12","author":"Tomita","year":"2001","journal-title":"Anticancer Drugs"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356513015140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356513015140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:12:29Z","timestamp":1761541949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356513015140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S1542356513015140"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2013.09.065","relation":{},"ISSN":["1542-3565"],"issn-type":[{"type":"print","value":"1542-3565"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of Pure Red Cell Aplasia in Patients With Hepatitis C Receiving Antiviral Therapy and an Erythropoiesis-Stimulating Agent","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2013.09.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 AGA Institute. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}